FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old (The San Francisco Examiner)
WILMINGTON, Del. ( Map ) - WILMINGTON , Del., Feb. 28 /PRNewswire/ -- AstraZeneca (NYSE: AZN ) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM(R) (esomeprazole magnesium) in children ages 1 to 11 years old for the short-term treatment of gastroesophageal reflux disease (GERD) for up to 8 weeks,(1) helping to address an important unmet need for ... FDA Needs Larger Budget, Agency Science Board Says (Medical News Today)
FDA needs an expanded budget of about $375 million in fiscal year 2009 to reverse longtime funding shortfalls, the agency's Science Board subcommittee said on Tuesday, CongressDaily reports. The subcommittee estimated that FDA needs an additional $2.2 billion over five years to bring the agency's funding level to $3.7 billion by FY 2013.